Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display

Cell Reports(2022)10.1016/j.celrep.2022.110348Source: DataRank Database

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.61)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

C. Anders Olson ORCID,Christopher O. Barnes ORCID,Wendy Higashide,M Aguilar Gonzalez,Justin Taft ORCID

Live enrichment

PubMed:35114110 PMC:PMC8769934 OpenAlex:https://openalex.org/W4220945510

NIAID NIH HHS

Grant: P01 AI138938

NIGMS NIH HHS

Grant: P30 GM133894

National Institutes of Health

Grant: 3P30GM133894-06S1

A Synchrotron Radiation Structural Biology Resource

National Institutes of Health

Grant: 1P01AI138938-01

Epitope-focused vaccine strategies against Zika virus

NIH

FWCI

2.61

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S221112472200064X/pdf

publisherhttp://www.cell.com/article/S221112472200064X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S221112472200064X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S221112472200064X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2022.110348

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciences

Keywords

EpitopeAntibodyVirologyGlycoproteinMessenger RNABiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Angiotensin-converting enzyme 2CoronavirusNeutralizing antibodyComputational biologyCoronavirus disease 2019 (COVID-19)ImmunologyGeneGeneticsMedicineMrna DisplayAntibody DesignAnti-spike AntibodySars-cov-2Sars-cov-2 VariantsQH301-705.5610Biology (General)Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display

FAIR Checklist

Authors (15)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)